Browsing Tag
Precision Oncology
23 posts
What makes SimonMed’s partnership with Lunit a turning point in clinical imaging?
SimonMed Imaging partners with Lunit to launch scalable, fine-tuned AI for chest X-ray reporting. Explore how this foundation model could change radiology forever.
Is 10x Genomics (Nasdaq: TXG) building the next TCGA for Asia? Inside the ASTRA atlas project
Discover how ASTRA and 10x Genomics are building a spatial cancer atlas to transform precision oncology in Asia-Pacific. Learn what’s driving this shift.
SOPHiA GENETICS integrates AI analytics with Complete Genomics sequencing to accelerate precision medicine adoption
Find out how SOPHiA GENETICS and Complete Genomics are revolutionizing cancer diagnostics through an AI-integrated sequencing platform driving precision medicine.
Is Oracle building the next operating system for oncology? Inside its AI push with Ci4CC
Oracle and Ci4CC join forces to drive AI and data science innovation in oncology. Find out how this partnership could reshape cancer care infrastructure.
How SOPHiA GENETICS’ AI Digital Twins could transform oncology treatment forever
Find out how SOPHiA GENETICS’ new AI-powered Digital Twins could revolutionize cancer care and reshape global oncology economics.
Why Jessa Ziekenhuis chose SOPHiA GENETICS to unify NGS workflows across oncology diagnostics
Find out how SOPHiA GENETICS is helping Jessa Ziekenhuis streamline genomic cancer diagnostics with a fully automated, AI-driven cloud platform.
NeoGenomics launches PanTracer Tissue and HRD-enhanced profiling to accelerate ovarian cancer treatment decisions
NeoGenomics launches PanTracer Tissue and PanTracer Tissue + HRD to fast-track ovarian cancer treatment with next-gen genomic profiling and rapid HRD testing.
ZAP Surgical expands into Latin America with first ZAP-X gyroscopic radiosurgery treatments in rural Paraguay
ZAP Surgical launches ZAP-X gyroscopic radiosurgery in rural Paraguay, enhancing access to non-invasive brain tumor therapy in underserved regions.
GE HealthCare unveils LesionID Pro and precision oncology suite to drive AI-led theranostics at SNMMI 2025
GE HealthCare launches LesionID Pro, Omni Legend, and MINItrace Magni at SNMMI 2025 to power AI-led theranostics and whole-body tumor imaging.
Hoth Therapeutics advances HT-KIT: Preclinical success sets stage for human trials and stock market interest
Hoth Therapeutics reports tumor suppression with no toxicity for HT-KIT. Learn how this biotech play could reshape cancer care and investor sentiment.